4 Insights on

• Reduced Frequency of Streptococcal Pharyngeal Infections
• Reduced Frequency of Pharyngitis
• Absence of Treatment-Related Side Effects
• Reduced Incidence of Pharyngitis

1 Insight on

• Increased Lactate Accumulation

3 Insights on

• Reduced Helicobacter pylori Colonization
• Reduced TNF-α Levels
• Reduced Gastric Mucosal Inflammation

15 Insights on

• Improved Gastrointestinal Health
• Improved Iron Absorption
• Reduced Pathogenic Load
• Improved Immunomodulation
• Reduced Intestinal Infections
• Reduced Gastrointestinal Infections
• Improved Bioavailability
• Reduced Pathogen Activity
• Improved Vaginal Epithelial Cell Adherence
• Improved Gastrointestinal Transit Survival
• Enhanced Pathogen Protection
• Modulated Host Immune Response
• Increased Production of Bioactive Peptides
• Enhanced Gastrointestinal Survival
• Enhanced Nutrient Bioavailability

21 Insights on

• Increased Gut Bifidobacteria
• Increased Bifidobacteria Levels
• Improved Immune Function
• Improved Natural Killer Cell Activity
• Increased Fecal Bifidobacteria Levels
• Increased Intestinal Bifidobacteria Levels
• Increased Serum Immunoglobulin A (IgA) Levels
• Maintained Natural Killer Cell Activity
• Increased Fecal Bifidobacteria
• Enhanced Natural Killer Cell Activity
• Increased Bifidobacteria Levels in Gut Microbiota
• Increased NK Cell Activity in Individuals with Baseline Low NK Cell Activity
• Increased NK Cell Activity
• Increased Intestinal Bifidobacterium Levels
• Maintenance of NK Cell Activity
• Increased Bifidobacteria in Fecal Microbiota
• Increased Serum IgA Levels
• Increased Fecal Bifidobacteria Numbers
• Stabilized Natural Killer Cell Activity
• No Significant Change in Hemagglutination Inhibition Titers
• Increased Bifidobacteria in Intestinal Microbiota

2 Insights on

• Reduced Cytotoxicity
• Increased Binding of Shiga Toxin Subunit B

13 Insights on

• Reduced Tumor Necrosis Factor Alpha
• Improved Average Daily Gain
• Improved Growth Performance
• Reduced Growth Decline After Infection
• Reduced Rectal Temperature
• Reduced ETEC Prevalence
• Reduced Serum Haptoglobin Levels
• Reduced Serum Interferon Gamma
• Altered Serum IL-6 Levels
• Reduced Serum TNF-α Levels
• Reduced ETEC-Positive Animals
• Improved Reaction Time
• Reduced IL-6 Concentration

2 Insights on

• Improved Intestinal Barrier Function
• Reduced Transepithelial Resistance

4 Insights on

• Enhanced Immune Response
• Reduced Pathogen Counts in Organs
• Improved Resistance to Respiratory Candida Albicans Infection
• Improved Respiratory Immune Function

5 Insights on

• Increased Pro-inflammatory Cytokine TNFα Levels
• Increased Colitis Severity
• Increased Histological Damage
• Disrupted Mucosal Barrier
• Reduced Levels of Anti-Inflammatory Cytokines

2 Insights on

• Reduced Body Weight
• Reduced Insulin Levels

4 Insights on

• Reduced Candida albicans Colonization
• Reduced Fluconazole Resistance
• Reduced Candida Albicans Survival
• Increased Candida albicans Eradication

6 Insights on

• Reduced Villus Height
• Reduced Average Daily Gain
• Worsened Fecal Scores
• Reduced Blood Serum IgA Levels
• Reduced Growth Performance
• Increased Fecal Score

2 Insights on

• Improved Immune Response
• Enhanced Nitric Oxide Production

2 Insights on

• Reduced Enteropathogenic Infection Risk
• Enhanced Epithelial Cell Defense Functions

5 Insights on

• Modulated Immune Response
• Reduced Pathogenic Colonies
• Enhanced Immune Evasion
• Reduced Pathogen Colonization
• Improved Gut Resilience

19 Insights on

• Reduced Total Cholesterol Levels
• Reduced Low-Density Lipoprotein Level
• Reduced Fibrinogen Levels
• Reduced Inflammatory Markers
• Reduced LDL Cholesterol
• Reduced C-Reactive Protein Levels
• Reduced Non-HDL Cholesterol
• Reduced Apolipoprotein B-100
• Improved LDL-C to HDL-C Ratio
• Improved ApoB-100/ApoA-1 Ratio
• Increased Plasma Deconjugated Bile Acids
• Reduced Plasma Non-Cholesterol Sterols
• Reduced Campesterol Absorption
• Reduced Sitosterol Absorption
• Reduced Stigmasterol Absorption
• Reduced Plant Sterols
• Reduced Total Cholesterol
• Reduced Apolipoprotein B Levels
• Improved Blood Lipid Profile

4 Insights on

• Reduced IBS Symptom Severity (Diarrhea-Predominant)
• Reduced Abdominal Pain Severity in Diarrhea-Predominant IBS
• No Significant Change in IBS Symptom Severity
• No Clinically Relevant Changes in Gastrointestinal Quality of Life

3 Insights on

• Increased Cure Rate of Bacterial Vaginosis
• Colonization with Lactobacillus jensenii Post-Treatment
• Improved Vaginal Health

2 Insights on

• Reduced Lung Injury
• Increased CD3+CD4+IFN-γ+ T Cell Count

4 Insights on

• Matured Antigen-Presenting Cells
• Reduced Pro-Inflammatory Cells
• Improved Antigen Presentation
• Increased Generation of T Regulatory Cells

1 Insight on

• Increased Fecal Calprotectin Levels

2 Insights on

• Improved General Health
• Reduced Risk of Common Cold

1 Insight on

• Reduced Intestinal Inflammation

3 Insights on

• Reduced Inflammation
• Reduced Immune Activation
• Reduced Arthritis Severity

4 Insights on

• Reduced Mutans Streptococci Colonization
• Increased Colonization by Mutans Streptococci
• Increased Colonization by Beneficial Bacteria (Bifidobacterium animalis subsp. lactis BB-12)
• Oral Colonization by Mutans Streptococci

3 Insights on

• Reduced Tumor Necrosis Factor Alpha
• Reduced Interleukin-8 Secretion
• Maintenance of Normal Intestinal Function

2 Insights on

• Increased Regulatory T Cell Populations
• Reduced Allergic Contact Dermatitis

2 Insights on

• Reduced Blood Pressure
• Improved Total Antioxidant Status

2 Insights on

• Improved Intestinal Barrier Function
• Reduced Alcohol-Induced Liver Injury